Mr Robert Klupacs
Mr. Robert Klupacs was appointed Chief Executive Officer of the Bionics Institute on 1 May 2017. He has over 30 years of international corporate experience in technology development, mainly in the fields of medical technologies and biotechnology, with a particular focus on healthcare.
Robert is scientifically trained in pharmacology and biochemistry. He is also an Australian-registered patent attorney with extensive experience in private and publicly traded companies as well as academia. He has been involved in the successful commercialisation of software, scientific instrumentation, food technologies and agricultural technology. He has unique skills in translating and commercialising early-stage intellectual property into products or investable corporate vehicles.
His broad career includes appointments as Director of Intellectual Property at AMRAD, COO of the Monash Institute of Reproduction and Development, CEO of Singapore-based ES Cell International, Managing Director and CEO of ASX-listed Circadian Technologies Ltd, and Executive Chairman of Bionic Vision Technologies Pty Ltd. He has served as a Non-executive Director for several early-stage companies and Co-operative Research Centres, and is currently a Non-executive Director of Bionic Vision Technologies Pty Ltd and ASX-listed Bio-Gene Technology Limited. Prior to accepting the CEO role at the Bionics Institute he founded and operated the technology development advisory company Magdajano Pty Ltd. He is a founder of 24 companies in Australia and Singapore, and was previously a member of the Pharmaceutical Industry Group and the Victorian Biotechnology Advisory Committee.
Robert is especially regarded for his ability to bridge cultural divides and knowledge gaps between academics, corporations, and the investment community. He is internationally recognised for his ability to lead start-up organisations to mature well-focused companies, his strong leadership, organizational and communication skills, and his track record of consistent and exceptional achievement.